News
Quidel Reports Second Quarter 2020 Financial Results
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the
BASF, Colgate-Palmolive, Estée Lauder, and Unilever Among Keynote Speakers at 2020 Veeva Quality & Regulatory Global Summit
Veeva Systems (NYSE: VEEV) today announced the featured keynote speakers at 2020 Veeva Quality & Regulatory Global Summit. Leaders from the world’s top consumer goods, chemical, and cosmetics
CORRECTING and REPLACING Quidel to Present Virtually at the Canaccord Genuity 40th Annual Growth Conference
Humana and Heal Announce National Partnership to Transform Home Care for Medicare Advantage Members and Others
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, and Heal, a market leader in transforming healthcare through in-home, comprehensive primary care, today
Dexcom Reports Second Quarter 2020 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2020.
Second Quarter 2020 Financial Highlights:
-
Revenue grew 34% versus the same
Pfizer Reports Second-Quarter 2020 Results
Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and reaffirmed all other components of its
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single nucleoside-modified
Agilent to Webcast Third-Quarter Fiscal Year 2020 Financial Results Conference Call
Agilent Technologies Inc. (NYSE: A) will release third-quarter fiscal year 2020 financial results after the stock market closes on Aug. 18. The company will also host a live webcast of its investor
Bayer AG Standardizes on Veeva Vault Clinical Applications Globally
Veeva Systems (NYSE:VEEV) today announced that Bayer AG (ETR:BAYN) has selected Veeva Vault Study Startup and Veeva Vault eTMF globally to accelerate site activation and improve visibility across
Global Survey Reveals Urgency to Accelerate Study Start-up
Accelerating study start-up is a top priority for life sciences companies according to the Veeva 2020 Study Start-up Pulse Report & Assessing Post-COVID Readiness, a global study start-up survey of
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the
Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams
Veeva Systems (NYSE: VEEV) today announced it is bringing Veeva CRM Engage Meeting functionality to Zoom and Microsoft Teams. Now customers will have greater flexibility and choice in how they
Syneos Health Strengthens Commercial Services with Veeva Commercial Cloud
Veeva Systems (NYSE: VEEV) today announced that Syneos Health (NASDAQ: SYNH), one of the industry’s largest providers of outsourced field teams, is offering biopharmaceutical customers Veeva
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE) today announced initial data from their ongoing German Phase 1/2, open-label, non-randomized
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based vaccine candidate against
Quidel’s Sofia® SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR; Product Supports U.S. Initiatives to Expand Access to COVID-19 Testing in Nursing Homes; Receives CE Mark for Use With Sofia® and Sofia® 2 Instruments
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2020 following the close of market on Thursday, August 6, 2020.
On the same day, at 2:00 pm Pacific
Waters Corporation Names Udit Batra President and Chief Executive Officer
Waters Corporation (NYSE:WAT) (“Waters” or the “Company”) today announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He
Quidel to Hold Second Fiscal Quarter 2020 Financial Results Conference Call on July 30th, 2020
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report second fiscal quarter 2020
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program
Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance
Pfizer Inc. (NYSE: PFE) announced today it has pledged $100 million to the new Antimicrobial Resistance (AMR) Action Fund, which launched today, to help address the significant global public health
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite
Veeva Vault Helps VentilatorChallengeUK Speed Production of More Than 13,000 Ventilators for COVID-19
In an effort to help overcome the shortage of ventilators during COVID-19, Veeva Systems (NYSE: VEEV) today announced that VentilatorChallengeUK used Veeva Vault QMS to accelerate ventilator
Quidel Announces Preliminary Revenue for Second Quarter 2020
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine